MedTrace Logo

Supporting Informed Decision Making About Multi-cancer Early Detection Testing

NCT06870916 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-03-20

No results posted yet for this study

Summary

To develop a new participant educational aid that can be used by participants to support informed decision-making about Multi-Cancer Early Detection (MCED) tests, which are new blood-based screening tests.

Conditions

  • Multi-cancer Early Detection

Interventions

OTHER

Multi-cancer Early Detection

Participants will participate in a focus group discussion asking about your knowledge, preferences, and concerns for MCEDs. During the focus group discussion, investigators will specifically talk about what the tests are and how to decide to get the test as well as their risks and benefits.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Robert Volk, PHD · M.D. Anderson Cancer Center

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-07
Primary Completion
2027-01-01
Completion
2027-01-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06870916 on ClinicalTrials.gov